Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Syndax Pharmaceuticals (SNDX) FCF Margin (2016 - 2020)

Historic FCF Margin for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to 4113.42%.

  • Syndax Pharmaceuticals' FCF Margin fell 7642100.0% to 4113.42% in Q4 2020 from the same period last year, while for Sep 2021 it was 22949.74%, marking a year-over-year decrease of 184437400.0%. This contributed to the annual value of 1160.91% for FY2024, which is N/A changed from last year.
  • Latest data reveals that Syndax Pharmaceuticals reported FCF Margin of 4113.42% as of Q4 2020, which was down 7642100.0% from 4827.7% recorded in Q3 2020.
  • In the past 5 years, Syndax Pharmaceuticals' FCF Margin registered a high of 1069.91% during Q4 2017, and its lowest value of 5648.28% during Q2 2020.
  • Its 5-year average for FCF Margin is 3715.02%, with a median of 3915.61% in 2017.
  • In the last 5 years, Syndax Pharmaceuticals' FCF Margin surged by 212229300bps in 2016 and then plummeted by -28924600bps in 2018.
  • Over the past 5 years, Syndax Pharmaceuticals' FCF Margin (Quarter) stood at 3415.08% in 2016, then surged by 69bps to 1069.91% in 2017, then crashed by -270bps to 3962.37% in 2018, then rose by 15bps to 3349.21% in 2019, then dropped by -23bps to 4113.42% in 2020.
  • Its last three reported values are 4113.42% in Q4 2020, 4827.7% for Q3 2020, and 5648.28% during Q2 2020.